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Summary: An enzyme enhanced luminescence immunoassay has been developed using the determination of serum
transferrin äs a model. The assay has been compared with an established radioimmunoassay, the details of which
have already been published (Wood, W. G. et al. (1980) Fresenius Z. Anal. Chem. 301,120). After comparison, the
luminescence immunoassay was introduced äs the routine method for determining transferrin levels in human serum.
The enzyme enhanced luminescence immunoassay uses a pyruvate kinase labelled transfemn äs tracer, which, after
the antibody-antigen reaction and subsequent bound-free Separation, is used to generate adenosine triphosphate
(ATP) from adenosine diphosphate (ADP) and phosphoenol pyruvate. The ATP is then monitored with a firefly
luciferin-luciferase reagent, using a luminometer äs detec'ion System.
The intra- and interassay coefficients of Variation were under 10% and under 13% respectively in the ränge 0.6-
4.5 g · liter"1. The stability of the lyophilised tracer was in excess of 5 months when stored at 4 °C, and the sensitivity
of the assay lay under 0.1 g per tube, although the detection limit of this type of assay System has not been fully
explored.
Ein enzympotenziefter Lumineszenzimmunoassay für die Bestimmung von Transfemn im Serum
Zusammenfassung: Es wurde ein enzympotenzierter Lumineszenzimmunoassay für die Bestimmung von Serumtrans-
ferrin entwickelt. Dieser neue Assay wurde mit einem Routine-Radiqimmunoassay verglichen, dessen Einzelheiten
bereits veröffentlicht sind (Wood, W. G. et al. (1980) Fresenius Z. Anal. Chem. 301,120). Später wurde der Lumines-
zenzimmunoassay als Routinemethode eingesetzt.
Der enzympotenzierte Lumineszenzimmunoassay verwendet ein Pyrüvatkinase-Transferrin-Konjugat als Tracer. Als
Maß für die Antigenkonzentration im Serum wird die Adenosintriphösphat (ATP) Erzeugung der Pyruvatkinase nach
der Immunreaktion verwendet. Das entstandene ATP wird in einem Luciferin-Luciferase System umgesetzt und das
produzierte Licht in einem Luminometer gemessen. Die Ergebnisse des enzympotenzierten Lumineszenzimmunoassay
korrelierten sehr gut mit denen des Radipimmunoassays. Der Variationskoeffizient sowohl für Intra- als für Inter-
assay-Bestimmungen lag unter 10 bzw. 13% im Konzentrationsbereich von 0,6 bis 4,5 g · liter"1.
Die Stabilität des lyöphilisierten Könjugates liegt weit über fünf Monate und die Empfindlichkeit des Assays liegt
unter 0,1 ^g pro Röhrchen, wobei die wirkliche Nachweisgrenze dieser Assaysysteme noch nicht erforscht ist.
Introduction This type of assay is not äs susceptible to quench effects
often seen in chemiluminescence immunoassays (2-4)
This article describes an alternative to radioimmuno- makinß * P°ssible to measure serum Proteins and hor-
• assay using a combination of enzyrüe and luminescence mones.
techniques which form the basis of the enzyme enhanced The principle of the test is a combination of an enzyme-
luininescenee immunoassay. The choice of transferrin äs labelled antigen using pyruvate kinase (EC 2.7.1.40)
Parameter was twofold, namely to reduce the need for a coupled to an ATP dependent luciferin-luciferase sys-
radioactive tracer, which had to be produced in the tem. The rate of ATP formation from ADP and phos-
laboratory, and to set up a robust assay System which phoenol pyruvate is proportional to the light intensity
would work under routine conditions. At this stage, the and inversely proportional to the concentration of non-
detection lirnits of the System were of secondary iinpor- labelled antigen in the System when the antibody-bound
tance. fraction is measured,
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Materials and Methods
Human transferrin was obtained form Behringwerke, Marburg
a.d. Lahn, FRG.
Crystalline pyruvate kinase and w-malcirnidobenzoyl-N-hydroxy-
succinimide ester were purchased from Sigma, Munich, FRG.
Suspensions of pyruvate kinase were obtained from Boehringer-
Mannheim, Mannheim, FRG.
Thc luciferin-luciferase reagent was generously donated by LKB
Munich, FRG.
AU buffer reagents were purchased from Merck, Darmstadt,
FRG. Ultrogel A6 chromatography gel was purchased from
LKB, D sseldorf, FRG,
Antibodies were raised in rabbits using human transferrin s
immunogen in Freund's complete adjuvant. The antisera were
used at an initial dilution of 1:1000.
The luminometer was provided by LKB-Wallac, Turku, Finland,
and was connected to a plotter and an integrator-printer, (Type
1250 Luminometer and plotter, with Datec integrator-printer).
The start reagent (ADP-phosphoenol pyruvate) was dispensed
from a Microlab P (Hamilton, Bonaduz, Switzerland).
Radioactive transferrin tracer was prepared s already published
(1).
Preparation ofthe pyruvate kinase labetted transferrin
l ml human transferrin solution (l μπιοί) was coupled to 70 μ\
(1.2 μπιοί) tfz-maleimidobenzoyl-N-hydroxy-succinimide ester at
pH 7.0 in 0.1 mol/1 phosphate buffer using the method viKit -
gawa (5). After coupling, the mixture was dialysed against
0.1 mol/1 phosphate buffer, pH 7.0 to remove unreacted
w-maleimidobenzoyl-N-hydroxy-succinimide ester and tetra-
hydrofurane. 25 nmol pyruvate kinase was added to the trans-
ferrin-m-maleimidobenzoyl-N-hydroxy-succinimide and aUpwed
to react for 30 min at ambient temperature, followed by 18 h
at 4 °C. The product so formed was separated on an Ultrogel A6
column (60 X 2 cm) using 0.02 mol/1 phosphate buffer contain-
ing 0.1 mol · liter'1 NaCl, pH 7.0. The fractions (2 ml) were
collected and tested for pyruvate kinase activity and for immuno-
reactive transferrin, after a prior dilution of 1:500. The fractions
containing pyruvate kinase activity and transferrin were pooled,
lyophilised and stored at 4 °C until use.
Preparation of solid-phase second antibody
20 g microcrystalline cellulose (Sigma) were suspended in 100 ml
0.05 mol/1 borate buffer, pH 6.0 and 100 mg NaI
 4 added. The
mixture was stirred and jcept at 70 °C for 2 hours. The presence
of aldehyde groups was monitored using Schiffs reagent (p-ros-
aniline saturated with 802). The oxidation of the vicinal hydroxyl-
groups of the cellulose matrix was seen by an increasing violet
coloration of the mixture. The reaction was completed after ca.
90 minutes. The microcrystalline cellulose was centrifuged, the
supernatant removed and the precipitate washed twice with
distiUed water. The precipitate was then resuspended in 200 ml
0.05 mol/1 Na2B4O7, pH 9.35 and 100 mg -y-globulin fraction of
the second antibody (donkey-anti rabbit IgG) added. The mix-
ture was stirred for 24 hours at 4 °C after which it was tested for
free aldehyde groups s above. If the reaction was positive,
ethanolamine (l mol/1, pH 9.35) was added until the Schiff-iezc-
tion remained negative. The slurry was then washed s above,
fmally being suspended in 200 ml H3BO3 (0.05 mol/1, pH 5.2)
and 200 mg NaBH4 added to stabilise the Schiff bases formed
during the coupling. The mixture was stirred for 30 min at
ambient temperature, being then washed s above, fmally being
suspended in 100 ml 0.05 mol/1 phosphate buffer, pH 7.5 con-
taining bovine serum albumin (5 g · liter"1) to saturate any
active sites. Before use in the assay the slurry was further diluted
1:10 with potassium phosphate buffer (0.05 mol/1, pH 7.8).
Enzyme enhanced luminescence and radioimmunoassaysfor transferrin
The radioimmunoassay was performed s already published (1)
with the following changes: The serum samples were diluted
l: 100 before assay and the Separation of bound and free antigen
was carried out using the solid phase second antibody described
above. The luminescence immunoassay was carried out identi-
cally with the radioimmunoassay with the exception ofthe
tracer. The assay s are summarised below:
20 μΐ serum or Standard (diluted 1:100 in 0,15 mol/l NaCl con-
taining EDTA (0.01 mol/1)).
50 μΐ antiserum (l: 1000 dilution in 0.05 mol/1 potassium phos-
phate buffer, pH 7.8 containing 0.2 g · liter"1 bovine serum
albumin), ' r
50 μΐ tracer (40,000 counts/min or ca. 2 pmol pyruvate kinase-
transferrin).
Allow to react for 45 minutes at ambient temperature
200 μΐ solid phase second antibody
Ailow to stand for 30 min with' occasional agitation.
Add l ml 0.15 mol/1 Kd and centrif ge for 7 min at 3000 g.
Aspirate off the supernate and rewash the precipitate with KC1
s above, centrifuging and discaiding the supernate.
The radioimmunoassay was then counted in a multi-channel
gamma counter (Nuclear Enterprises Type NE 1600) for l mfav·
ute, the data processing being carried out online with a GBM
4032 desk top Computer using a spline function (6) with an
adapted Programme described by Marschner et al. (7), in which
an autoiiiatic smoothing routine had been incprporated.
The luminescence immunoassay precipitates were treated s
follows after the KG wash sequence:
400 μΐ Tris-Hd buffer (0.1 mol/U pH 7.8) containing EDTA
(0.01 mol/1) and
200 μΐ of a mixture of ADP, ph sphoenol pyruvate (both
0.1 mmol/1) and ATP-monitoring reagent (1+1+2 by Volume)
were added to the precipitate and the ATP production monitored
in the luminometer with pl tter trace and 10 second integral
print-outs.
The rate of ATP production was expressed s mV · s"1. The
reaction was followed from the 31 st to the 60th secorids pver
3 successive 10 second periods, the mean mV change for each
period calculated, checked for linearity and the mean value
used for data processing.
Results
Constancy ofA TP production
In a series of 1000 measurements, the Variation ofthe
slope dV/dt was under l % in each case for the time
interval 31—60 seconds for the 3 suecessive time inter-
vals of 10 seconds, i. e. the slope was fully linear during
the period of measurenient.
Intra- and intef-ass y coefficients of Variation
The intra-assay coefficient of Variation (CV)measured at
three points along the Standard cufve was s follows:
Test serum 1: mean 4.08 g - liter"1, CV 7.05%, n = 20
Test serum 2: mean 2.26 g · liter"1, CV 8.75%, n = 20
Test serum 3: mean 0.75 g - liter"1, CV 9.70%, n = 20
The inter-assay CV for the same control sera was s
follows:
Test serum l: mean 3.58 g - liter"1, CV 10.4%, n = 20
Test serum 2: mean 2.13 g - liter"1, CV 11.8%, n = 20
Test serum 3: mean 0.82 g - liter"1, CV 11.4%, n = 20
The inter-assay CV was deterrnined from tue mean of
duplicate values frorri each assay.
J. C n. Chem. Clin. Biochem. / VcU. 20,1982 / No. 2
Fricke, Strasburger and Wood: Luminescence immunoassay of transfenin 93
Correlation ofthe enzyme enhanced luminescence
immunoassay with the radioimmunoassay
The correlation between the luminescence- and radio-
immunoassays was made from data from 14 assays carried
out siniultaneously for both methods. The only differ-
ence in the assays was the tracer. Values from the radio-
immunoassay were entered äs x, those from the lumi-
nescence immunoassay äs y. 147 serum samples were
used in the comparison.
The regression line y = a + bx had the following coeffi-
cients: a = 0.01, b =1.05, with a correlation coefficient
of r = 0.960. The mean value for the radioimmunoassay
was 2.13g- liter'1 (ränge 0.11-7.58 g · liter"1) and for
the luminescence immunoassay 2.24 g · liter"1, (ränge
0.10-7.34 g-liter"1).
The reference ränge for both assays was the same, i.e.
2—4 g · liter"1, for persons with normal body iron Status
äs determined for this laboratory (8).
Standard curve data
The data from two typical Standard curves is shown in
table l. It can be seen that the form of the luminescence
and radioimmunoassay Standard curves are similar. The
data is expressed in tabular form to allow a better com-
parison of the data received.
Tab. 1. Data from the enzyme enhanced luminescence immuno-
assay and radioimmunoassay Standard eurves - assays
carried out simultaneously.
Standard transferrin
g · liter"1
0
0
0.5
0.5
1.0
1.0
2.0
2.0
4.0
4.0
8.0
8.0
ÜB*
ÜB
Enzyme enhanced
luminescence immuno-
assay
Rate of ATP
production dV/dt
(mV - s'1)
52.8
51.7
36.2
36.6
30.4
32.0
24.8
25.2
19.1
18.0
13.8
14.6
7.30
6.68
Radio-
immunoassay
(counts/min)
12545
12169
8239
8260
7459
7429
6272
6382
5467
5195
4108
4098
. 2953
2791
-50% intercept - Enzyme enhanced luminescence immunoassay
0.94 g - liter"1, Radioimmunoassay 0.93 g · liter"1. Sensitivity
Gower limit of detection), luminescence immunoassay and radio-
immunoassay < 0.1 g · liter'1.
* ÜB - non-specific binding (antibody blank).
Recovery studies on the enzyme enhanced luminescence
immunoassay
Human transferrin was added to two sera with known
endogenöus transferrin levels (determined äs the mean
values from duplicate determinations in 20 assays in the
radioimmunoassay). One serum was from a patient on
haemodialysis, with diminished transferrin, the other
was a patient with normal body iron Status (haemoglobin
149 g · liter"1, HbE 32 pg, serum ferritin 102 % - liter"1
(8)). The results for the mean recovery in three successive
assays is shown in table 2.
Tab. 2. Recovery data from transferrin added t o two sera at
different concentrations. The results are the mean of
duplicate determinations carried out in three successive
assays.
Serum A had a mean value of 0.22 g · liter"1, serum B
had a mean value of 2.24 g · liter"1, (both measured in
duplicate in 20 assays using the radioimmunoassay äs
reference method).
Serum Transferrin added Transferrin found Recov-
(g.liter"1) (g-liter"1) ery
A
B
0
0.5
1.0
2.0
5.0
0
0.5
, 1.0
2.0
5.0·
0.21
0.69
1.06
2.17
5.04
2.28
2.79
3.40
4.22
7.33
0.97
0.98
0.98
0.97
_
1.00
1.04
0.99
1.01
Discussion
This article describes an alternative to radioimmuno-
assay for the determination of proteins in biological
fluids. The System chosen with transferrin äs analyte was
not meant to test the potential sensitivity of the method,
but rather to establish a routine assay robust enough to
be carried out*y all laboratory personnel. The assays
correlate well with each other, the reference ränge not
having to be changed when the luminescence immuno-
assay replaced the radioimmunoassay for the routine
determination of serum transferrin.
Preliminary data (Fricke - unpublished data 1981) has
shown that the pyruvate kinase labelled antigen coupled
with the firefly luciferin-luciferase System is sensitive
enough to measure insulin levels in untreated sera with
an assay sensitivity of under 5 mU/1, using an analogous
assay System to the one here described. The advantage
of the System used here, over conventional chemilumi-
nescence immunoassays is that the quenching effect due
to proteins is absent. This is due to the fact that the
light-generation System is independent of the antigen-
antibody binding site.
The use of a solid-phase second antibody Separation step
allows the removäl of potential interference from serum
components. The use of microcrystalline cellulose äs
support, paradox though it may seem, does not appear
to affect the linearity of the light Output, although for
the rnore sensitive assays, the volume ofthe second anti-
body must be reduced to keep potential light absorp-
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tion to a minimum. This can be done by increasing the
amount of second antibody per unit mass of support, or
by substituting the cellulose for a more translucent
material, for example activated polymer beads.
Although this assay has been built up using pyruvate
kinase äs label, other enzymes with lower molecular
weight appear to be better for hapten assays, for example
myokinase (EC 2.7.4.3). One is not limited to the ADP-
ATP System coupled to firefly luciferin-luciferase, and
other enzymes with high turnover rates, for example
glucose-6-phosphate dehydrogenase (EC 1.1.1.49) can
be used coupled to an NADP-NADPH dependant
bacterial luciferin luciferase System.
The main problem of introducing such assays is the
problem of automation. One must compare the present
state of luminescence detection Systems currently avail-
able with the availability of automatic gamma-counters
in the early 1960s. At the present time, there is only
one automatic luminorneter available (LKB 1251) which
can sample 25 tu!bes sequentially.
The future of luminescence immunoassay lies in the
availability of kits and süitable monitoring equipment,
äs before this, there is little iiicentive to change from
radioimmunoassays to these alternative techrjdques.
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